Kyle Blankenship, the managing editor of biopharmaceutical news outlet Endpoints News, is leaving for a non-journalism job.
His last day is Friday.
Blankenship has been at Endpoints since December 2020, first as a senior editor. He has been managing editor since February 2021.
He previously worked as an associate editor at FiercePharma, as a city editor and investigations reporter at the Killeen Daily Herald in Texas and as a copy editor of the Bryan-College Station Eagle, also in Texas.
Blankenship holds a master’s degree from the University of North Texas and a bachelor’s degree from Texas A&M University.
Lachlan Cartwright and Ravi Somaiya of Breaker report that Wall Street Journal editor in chief…
Alex Konrad, a former senior editor at Forbes who left in January, has started Upstarts…
Rebecca Blumenstein, president of editorial for NBC News, will receive the 2025 Distinguished Achievement Award…
Axios reporter Tim Baysinger, who has been covering media deals, is leaving the news organization…
Nonprofit news service NOTUS has hired Arielle Elliott to be its chief executive officer. As…
Katherine Hamilton is now a real-time news reporter at The Wall Street Journal. Hamilton previously…
![](data:image/svg+xml;charset=utf-8,<svg height="200px" width="200px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="29px" width="180px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="75px" width="75px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)